Semaglutide 5mg pen dosage: where it sits in your Wegovy schedule

You've seen "5mg semaglutide" somewhere, here's what's actually going on

Semaglutide comes in more than one product and more than one form, and the strengths used depend entirely on what the medicine is licensed for. Rybelsus, the oral semaglutide tablet for type 2 diabetes, is available in 3mg, 7mg, and 14mg strengths. The Wegovy tablet (a separate oral formulation approved in the UK in June 2026 for weight management) uses a different set of steps altogether: 1.5mg, 4mg, 9mg, and a 25mg maintenance dose. None of those are 5mg either.

The Wegovy injection pen has its own schedule: 0.25mg to start, stepping up through 0.5mg, 1.0mg, 1.7mg, and 2.4mg as a standard maintenance level. A 5mg pen dose simply does not exist within any UK-licensed semaglutide programme. If you have come across that figure on a website, forum, or marketplace listing, it is likely either a mistake, a description of an unlicensed product, or content written for a different country's regulatory framework.

This matters beyond semantics. The NHS semaglutide guidance is clear that doses must follow the prescribed schedule, and deviating from it (whether by taking too much or skipping steps) increases the risk of side effects without improving outcomes. If you are unsure about what dose you are on or what comes next, the right conversation is with your prescriber.

How the Wegovy titration schedule is actually structured, and why it moves slowly

The four-week steps are not arbitrary. Starting at 0.25mg gives your digestive system time to adjust to the medicine before the dose climbs. Nausea, bloating, and changes in appetite are most noticeable in the early weeks, and the slow escalation is specifically designed to reduce them. The 2.4mg maintenance dose (where most clinical trial participants spent the majority of their time) is where the significant appetite-suppression effect is most pronounced.

The MHRA's approval in April 2026 of a dedicated 7.2mg single-dose pen extended the upper end of that schedule for people with a BMI of 30 or above. In trials, participants on 7.2mg lost an average of around 20.7% of their body weight over 72 weeks, narrowing the gap with tirzepatide's headline results. You can read more about how the different Wegovy doses sit within the full treatment pathway, including what the 7.2mg approval means for people already on 2.4mg.

The titration timeline also has a ceiling. NICE's recommendation for semaglutide (TA875) specifies that if a patient has not lost at least 5% of their body weight after six months at the highest tolerated dose, continuing treatment should be reviewed. That threshold is not a punishment; it is a clinical check that the medicine is actually doing what it is supposed to do for that individual.

What happens if a dose step is missed or skipped

This is a question our prescribers hear regularly, and the honest answer is: it depends on the specifics, and only your prescriber should advise you. What the evidence does tell us is that jumping dose steps to speed up weight loss does not improve results and does substantially increase the likelihood of gastrointestinal side effects, nausea, vomiting, and stomach discomfort are reported most often in people who escalate faster than the schedule allows.

For a broader picture of how individual dose adjustments are handled across the full semaglutide dosage pathway, including what to do after a missed injection, the Patient Information Leaflet that comes with your pen is the primary reference. Every pen dispatched through a regulated pharmacy arrives with that leaflet included, your specific instructions are in there, not on a general website.

If you are thinking about what the highest safe level looks like, the maximum dosage of semaglutide for weight management is now 7.2mg weekly under UK licensing, though not everyone will need or be suitable for it.

Getting the dose right: the role of clinical oversight at every stage

Dose decisions in semaglutide treatment are not mechanical. A prescriber reviewing your progress looks at how much weight you have lost, how you are tolerating the current dose, whether any side effects are affecting your daily life, and whether there are any reasons to pause or adjust. That review happens before every repeat, it is not a rubber stamp.

The first dose of Wegovy carries its own considerations, and so does each step up. If you are weighing up whether Wegovy is the right treatment or want to understand the full picture of what to expect, the Wegovy overview covers both how it works and what the clinical evidence shows.

At nume, a GPhC-registered Independent Prescriber reviews every consultation personally, a real clinician reads your answers, not software. If you are ready to explore whether semaglutide treatment is suitable for you, you can check eligibility and speak to our prescribers through a free consultation. The medicine arrives via DPD the next working day in plain, unbranded packaging, with tracking sent to your phone. Straightforward from first step to front door.

For context on what private semaglutide treatment typically involves in terms of cost and what is included, the Wegovy where to buy page covers the access routes and what a transparent price should include.